Scientists in Bristol developing a vaccine for Hantavirus say they hope it could eventually become a routine travel jab after a recent deadly outbreak on a cruise ship. Three people died after an ...
A new study suggests that prostate cancer screening could reduce deaths by 13 per cent, as cancer experts in the UK assess ...
We have an update with Microbix, who just put out their Q2 numbers this morning. So hopefully, everyone's had a chance to review those. With me on the call, I have Cameron Groome, CEO; Ken Hughes, COO ...
H1 Revenues of $7.6 million and Controlled Net Loss MISSISSAUGA, ON / ACCESS Newswire / May 14, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF)(Microbix®), a life sciences innovator, ...
MIT engineers developed a new way to amplify the T cell response to mRNA vaccines, using an mRNA adjuvant. This approach could lead to much more powerful cancer vaccines and stronger protection ...
Point of Care Facilities Authorized to Use GenBody’s Nasopharyngeal and Anterior Nasal Swab Test Kits to Test People Without Symptoms JURUPA VALLEY, California--(BUSINESS WIRE)--GenBody America is ...
Patented Algorithm Designed to Help Identify Otherwise Dangerous Prostate Tumors Earlier Using Repeat Blood Test ResultsLicensing Agreement ...
The discovery of old bones could finally reveal the real life story of d'Artagnan—who has long been cast in the shadow of ...
New vaccine progress: University of Bath scientists have created a new hantavirus antigen showing strong early results, with human trials planned. Innovative delivery method: The vaccine uses mRNA and ...
Artificial intelligence is increasingly being used to help scientists accelerate drug discovery and search for new treatments. But for AI tools to work effectively, researchers need to know whether ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results